Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Prepaid Assets (2016 - 2025)

Rein Therapeutics (RNTX) has disclosed Prepaid Assets for 10 consecutive years, with $692000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Prepaid Assets changed N/A to $692000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $692000.0, a N/A change, with the full-year FY2024 number at $116000.0, down 86.85% from a year prior.
  • Prepaid Assets was $692000.0 for Q2 2025 at Rein Therapeutics, down from $864000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.2 million in Q4 2021 to a low of $116000.0 in Q4 2024.
  • A 5-year average of $956250.0 and a median of $781500.0 in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 99.68% in 2022, then crashed 86.85% in 2024.
  • Rein Therapeutics' Prepaid Assets stood at $2.2 million in 2021, then plummeted by 72.69% to $606000.0 in 2022, then skyrocketed by 45.54% to $882000.0 in 2023, then plummeted by 86.85% to $116000.0 in 2024, then soared by 496.55% to $692000.0 in 2025.
  • Per Business Quant, the three most recent readings for RNTX's Prepaid Assets are $692000.0 (Q2 2025), $864000.0 (Q1 2025), and $116000.0 (Q4 2024).